Abstract Aiming to overcome poly(lactic acid) (PLA) limitations regarding flammability and high costs, a highly refractory clay (RC) was employed to produce PLA/RC composites. The composites with clay contents of 0, 2.5, 10 and 15 wt% were produced by extrusion, conformed by injection molding, and characterized by thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), mechanical analysis, scanning electron microscopy (SEM), Fourier Transform Infrared Spectroscopy (FTIR), statistical analysis of variance (ANOVA) and flammability tests. The overall thermal stability of the materials was not affected by the incorporation of clay to the polymer matrix; improvements around 25% for Young’s modulus and slight increase in flexural and impact strength, when compared to neat PLA, were obtained; ANOVA showed the possibility of incorporating higher loads of clay, 10-15 wt%, in order to make the final material more cost effective. PLA/RC composites demonstrated self-extinguish behavior for the flame even at a lower clay content.

Resumo Após décadas de ostracismo, os recentes avanços no tratamento do melanoma trouxeram uma nova realidade para pacientes, médicos e pesquisadores. Enquanto anticorpos monoclonais voltados a moléculas envolvidas na modulação da interação entre células do melanoma e do sistema imune consolidaram o uso da “imunoterapia”, um melhor conhecimento acerca das aberrações genômicas envolvidas na carcinogênese do melanoma viabilizaram o desenvolvimento de inibidores da via mitogen-activated protein kinase pathway (MAPK), o que também resultou em ganhos significativos em taxas de resposta e sobrevida. Consequentemente, novas modalidades de tratamento foram aprovadas para uso clínico nos Estados Unidos e na Europa, incluindo os bloqueadores de correceptores imunes ipilimumabe, nivolumabe e pembrolizumabe, o herpesvírus oncolítico talimogene laherparepvec (T-VEC), e os agentes-alvo vemurafenibe, dabrafenibe, cobimetinibe e trametinibe. Nesse artigo, revisamos os resultados que trouxeram novas alternativas para a prática clínica e discutimos a incorporação desses avanços ao cuidado de pacientes no Brasil.

Summary Following decades of relative ostracism, advances in the treatment of melanoma have brought a new reality for patients, physicians and researchers. While antibodies targeting molecules involved in the modulation of the interaction between melanoma and immune cells changed the meaning of the term “cancer immunotherapy,” a better characterization of the molecular aberrations involved in melanoma carcinogenesis prompted the development of inhibitors of the mitogen-activated protein kinase pathway (MAPK) that also led to significant improvements both in response rates and survival. As a result, new drugs have been approved for clinical use in the United States and Europe, including the immune-checkpoint blockers ipilmumab, pembrolizumab and nivolumab, the oncolytic herpesvirus talimogene laherparepvec, and the targeted-agents vemurafenib, dabrafenib, cobimetinib and trametinib. In this article, we review the results of studies that brought new approaches to the bedside and discuss how these developments are being incorporated into the care of patients in Brazil.

Abstract Introduction Immobilization in a hip spica cast is required in surgical and nonsurgical treatments for children aged three months to four years diagnosed with developmental dysplasia of the hip. Skin complications are associated with the use of the spica cast in 30% of the cases. This research explores the use of photogrammetry and rapid prototyping for the production of a lighter, shower friendly and hygienic hip orthosis that could replace the hip spica cast. Methods Digitalized data of a plastic dool was used for design and fabrication of a customised hip orthosis following four steps: 1) Digitalization of the external anatomical structure by photogrammetry using a smartphone and open source software; 2) Idealization and 3D modeling of the hip orthosis; 3) Rapid prototyping of a low cost orthosis in polymer polylact acid; 4) Evaluation tests. Results Photogrammetry provided a good 3D reconstruction of the dool's hip and legs. The manufacture method to produce the hip orthosis was accurate in fitting the hip orthosis to the contours of the doll. The orthosis could be easily placed on the doll ensuring mechanical strength to immobilize the region of the hip. Conclusion A new approach and the feasibility of both techniques for hip orthosis fabrication were described. It represents an exciting advance for the development of hip orthosis that could be used in orthopedics. To test the effectiveness of this orthosis for developmental dysplasia of the hip treatment in newborns, material and mechanical tests, design optimization and physical tests with patients should be carried.

Purpose To assess the activity, safety and treatment patterns of sunitinib in patients with poor-risk metastatic renal cell carcinoma (mRCC). Materials and Methods We retrospectively reviewed the charts of poor risk patients treated with sunitinib from October 2006 to July 2013 who met the eligibility criteria. The primary endpoint was overall survival (OS). Tumor radiological response was measured according to RECIST 1.1 and adverse events (AEs) were assessed through standard criteria. Results Median OS was 8.16 months (95% CI, 5.73-10.59). Of the 53 patients included in this analysis, 9 (17.0%) achieved partial response, 12 (22.6%) had stable disease. Median treatment duration was 3.30 months (95% CI: 1.96-4.63) and 26.4% of patients discontinued treatment due to toxicity. Grade 3 or higher AEs occurred in 39.6% of patients, the most common being fatigue (15.1%), neutropenia (9.5%), nausea, vomiting and diarrhea (7.5% each). Discussion Sunitinib may benefit some unselected poor-risk patients, although the rates of AEs and drug discontinuation suggest a need for careful patient monitoring.

A reconstrução cirúrgica do ligamento cruzado posterior (L.C.P.) do joelho ainda permanece como um grande desafio terapêutico. Neste trabalho avaliamos 30 pacientes submetidos à reconstrução cirúrgica do L.C.P. com a técnica de fixação do enxerto tendíneo no leito tibial por abordagem direta ("INLAY"). 28 pacientes eram do sexo masculino e 2 do feminino, com idade média de 31,10 anos. O tempo médio de lesão foi de 34,24 meses Em 67% dos casos a lesão foi secundária a acidente motociclístico. As lesões condrais e do ligamento cruzado anterior (L.C.A.) do joelho estavam presentes em 67% e 33% dos casos, respectivamente. Os pacientes foram avaliados objetivamente (teste de gaveta posterior) e subjetivamente (Escala de Lysholm). O seguimento pós-operatório médio foi de 21,7 meses. Cerca de 66% dos casos foram classificados como bom e excelente na avaliação subjetiva e objetiva. A análise estatística apresentou comportamento semelhante para as duas avaliações.Os resultados clínicos pós-operatórios obtidos neste trabalho têm nos encorajado a seguir com esta técnica cirúrgica.

Surgical reconstruction of the knee posterior cruciate ligament (P.C.L.) still remains as a major therapeutic challenge. In this paper, we assessed 30 patients submitted to surgical reconstruction of the P.C.L. with a technique of tendinous graft fixation on tibial bed by direct approach ("INLAY"). Twentyeight male patients and 2 female patients, with mean age of 31.10 years, participated on the study. The average injury time was 34.24 months. In 67% of the cases, injury was secondary to motorcycle accidents. Chondral injuries and knee anterior cruciate ligament (ACL) injuries were present in 67% and 33% of the cases, respectively. Patients were assessed objectively (posterior drawer test) and subjectively (Lysholm's Scale). Mean post-operative follow-up time was 21.7 months. About 66% of the cases were rated as good and excellent at the subjective and objective evaluation. The statistical analysis showed a similar behavior for both evaluations. Post-operative clinical outcomes achieved in this study have encouraged us to keep using this surgical technique.